MSB 3.16% $1.31 mesoblast limited

Ann: COVID ARDS Trial Respiratory Outcomes Presented, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. Hez
    227 Posts.
    lightbulb Created with Sketch. 26
    Well yes it IS like being 8 years old again and waiting for Christmas. A day feels like a week, a “few” weeks seems interminable.
    However this announcement was just telling us a presentation was made to the Pulmonary Disease Conference and what exactly was presented, information shareholders would want to know, and need to know. The conference must surely help to get the message out there that Rem-L would provide better outcomes for so many.
    I just wish they would take a sack full of the stuff down to ICU in Sydney hospitals for Covid sufferers there. Numbers increasing every day.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.